• Shelf life extended from 24 to 36 months in Europe
  • Competitive advantage in terms of optimizing the supply chain costs and convenience for distributors, pharmacists and patients

Liege, Belgium,4 August 2020 - 7:30 CEST - Mithra (Euronext Brussels: MITRA), a company dedicated to Women's Health, today announces that the European Authorities have approved the extension in the shelf life of its vaginal contraceptive ring Myring™ from 24 to 36 months, allowing distributors to optimize their supply chain management.

Attachments

  • Original document
  • Permalink

Disclaimer

Mithra Pharmaceuticals SA published this content on 04 August 2020 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 04 August 2020 05:41:02 UTC